BioCentury
ARTICLE | Clinical News

Oral antibacterial agent: IG's Novavax division will begin a Phase I trial in the fourth quarter

September 18, 1995 7:00 AM UTC

IGI Inc. (IG), Buena, N.J. Product: Oral antibacterial agent Indication: Helicobacter pylori infection Status: IG's Novavax division will begin a Phase I trial in the fourth quarter ...